See also this year's filing and all EDGAR filings for this company.
PDF Report 0001133416_2026_Galectin_Therapeutics_INC.pdf
Logs
Graph
Absolute values for 0001133416, Galectin Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 19,436,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 96,000 |
| 4 | LiabilitiesCurrent | 8,030,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 137,697,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 5,822,527 |
| 9 | ResearchAndDevelopmentExpense | -7,576,167 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -10,323,699 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 19,532,000 |
| 1 | Liabilities | 145,727,000 |
| 2 | Expenses | -1,753,640 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -126,195,000 |
| 5 | NetIncome | -8,570,059 |
| 6 | ComprehensiveNetIncome | -8,570,059 |
| 7 | BaseVar | 88,668,170 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -3.43 |
| 9 | EconomicCapitalRatio | 0.549 |
Edgar->Model Mapping
Feature Distribution
Change over Time
